Optibiotix Health Share Discussion Threads

[owenmo] 13/7/2017 19:04

Yes TT; ramp and de-ramp to suit your trading strategy; nice one. Market forces and all of that.

[elrico] 13/7/2017 19:00

Too close to the company....what next...falling in love :)

TT - You have demonstrated your ignorance and don't even realise it. Doe's it sound familiar. You have an allie in Michaelmouse. Something in common to. He also blamed TW for his losses.

I think I have made my points, purpose achieved.

[talkingtrade] 13/7/2017 18:57

You do realise that while your hanging on here major holders are offloading...

[talkingtrade] 13/7/2017 18:55

Hence we sit at 60p...and that IMO will break in the next few trading days.

[talkingtrade] 13/7/2017 18:55

Elrico,You can post my previous posts. Doesn't bother me.But over time I've changed my view and traded accordingly. The only fact and real material news we've had from the company in two years are the cholesterol results. Hence, surge from 40p to £1.Since then it's all been vague BS RNS. No transparency and everything shrouded in NDAs and secrecy.

[elrico] 13/7/2017 18:52

TT - Facts are fact. If you don't understand them you should just hand over your funds to a fund manager and leave your emotions at the door.

TalkingTrades - 14 Apr 2016 - 10:12:04 - 11534 of 24927OptiBiotix - Better Science, Better Health. Better buy some! - OPTIThis is massive!!!!

'OptiBiotix's first product, developed using its OptiScreen(R) platform, is a bacterial strain targeting cholesterol reduction. The product, provided as a supplement, successfully completed human studies in September 2015. There were no safety, compliance, or tolerance issues reported by volunteers during the study. When compared to a placebo the results demonstrated a 7.2% reduction in LDL cholesterol (bad cholesterol) across the test group with a 12.4% reduction seen in females, and a 15% reduction in the 50-55 age groups. Volunteers with total cholesterol levels higher than 6.0mmol/L group had even higher reductions of LDL cholesterol (36.7%), an efficacy more in-line with pharmaceutical treatments such as statins. In addition, high efficacy pilot scale manufacturing studies have demonstrated high production yields leading to a low cost of production and very high freeze drying survival."

LDL reduction.

Massive!!!!
TalkingTrades - 14 Apr 2016 - 07:55:56 - 11487 of 24927OptiBiotix - Better Science, Better Health. Better buy some! - OPTIIMO company had sufficient cash for the next 2-3 years. Within that period expect more JVS, revenue based products on shelves and maybe more placings with IIs but at substantial premium to today's price.

TalkingTrades - 14 Apr 2016 - 07:41:35 - 11479 of 24927OptiBiotix - Better Science, Better Health. Better buy some! - OPTIOverall very good progress and well positioned for the future.

[talkingtrade] 13/7/2017 18:50

How was it eloquent.It was vague at best. He's answered nothing and clarified nothing. Just like the company.It's all speculation on he's behalf.

[talkingtrade] 13/7/2017 18:43

Elrico,Again vague answers. You've protected yourself with the NDAs.The YSF shares were absorbed by the PIs.Hence price falling to 60p. We are going to have to agree to disagree.Building a business clap trap doesn't wash with me.How about broker forecast.There simply isn't enough transparency here.Oh and do you recall the little matter of SOH sale of his company to 3M. There was a slight discrepancy between what he says happened and what actually happened.Oh and your communications with SOH and fact checking. He can easily ignore some of your presumptions as it's not an official FCA compliant document you are producing. So don't kid yourself old chap.He's probably playing you like an old guitar.Your too close to the company..hence blinded by the counter argument now..

[michaelmouse] 13/7/2017 18:37

Investors will need significant news on revenue generation from Opti in the very near future or the chart won't hold here, and once the share price falls below the 60p support then where it will stop is anybody's guess?

It is looking like a 4d pharma scenario. Not even a dead cat bounce today.

We're nearly 8 months into their financial year and there's not a whisper about revenues, cash remaining, cash burn etc. That's not a good sign.

[michaelmouse] 13/7/2017 18:18

Blimey it appears talkingtrade(s) has done a quick U-turn. Anyway mostly best to watch and wait for events to unfold. I hope for all your sakes that this is the 1 out of 10 I get wrong. I doubt it though:-

[owenmo] 13/7/2017 17:41

Methinks TT protests too much; unhealthily (unethically?) so.

[talkingtrade] 13/7/2017 17:34

Just read Scottys post on other thread.It's like ground hog day for the past 2 years...Lol...lol..

[talkingtrade] 13/7/2017 17:28

Oh, and the old NDA argument will come out with regards to these JV deals.BS. There's no detail because the MNs are taking no risk and it's based on possible future revenues.If they were that confident make a big upfront payment for one of the biome strains. Take a major stake in the company or biome strainOhh..don't tell me...SOH wants to remain in total control.Lol..lol..

[neftanikoff] 13/7/2017 17:11

I dont exspect an answer, but who is TS ? (apart from being TT)

Elrico, i see you are carrying on the debate now with TT on the other thread, you see JudiJudi, whether you like it or not, some of the best people on here are having a go with him. I am not entirely sure that this the right thing to do, as i told Primal
However, i am looking forward Elrico, to your reply to TT's most recent post, where he asks you over half a dozen questions, my money is on you to deliver, although i see he has pre guessed your reply to some, eg things like others not undestanding the science

[talkingtrade] 13/7/2017 17:10

Please give me the details of the agreement between Tata chemicals and OPTI??Investment from Tata, which products, upfront payments, projected revenues etc ..